Form 990 for tax year 2023
Filed by CLAYTON FOUNDATION FOR RESEARCH.
Totals
- Total revenue
- $11,043,790
- Total expenses
- $10,750,530
- Contributions and grants received
- $8,075,000
- Grants paid
- $150,000
- Program service revenue
- $96,250
- Investment income
- $2,729,478
- Other revenue
- $143,062
- Total assets, end of year
- $130,572,468
- Total liabilities, end of year
- $7,121,038
- Net assets or fund balances, end of year
- $123,451,430
- Program services expenses (Part IX)
- $9,405,819
- Management and general expenses
- $1,344,711
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $9,405,819
Program services were 87.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$8,075,000
-
2a · Program service revenue: Sponsored Research
total $96,250 · excluded $96,250
-
3 · Investment income
total $1,938,814 · excluded $1,938,814
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $143,062 · excluded $143,062
-
6d · Net rental income or loss
total $0
-
7a · Gross sales of assets other than inventory
securities $2,785,823
-
7b · Less cost or other basis and sales expenses
securities $1,995,159
-
7c · Gain or loss
securities $790,664
-
7d · Net gain or loss
total $790,664 · excluded $790,664
-
8c · Net income from fundraising events
total $0
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $150,000 · program services $150,000
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $1,675,787 · program services $1,390,346 · management and general $285,441
-
6 · Compensation of disqualified persons
total $497,743 · program services $348,420 · management and general $149,323
-
7 · Other salaries and wages
total $2,583,482 · program services $2,427,568 · management and general $155,914
-
8 · Pension plan contributions
total $358,217 · program services $323,101 · management and general $35,116
-
9 · Other employee benefits
total $1,174,817 · program services $984,227 · management and general $190,590
-
10 · Payroll taxes
total $198,780 · program services $184,030 · management and general $14,750
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $18,571 · program services $13,928 · management and general $4,643
-
11c · Fees: accounting
total $52,329 · program services $41,863 · management and general $10,466
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $286,997 · management and general $286,997
-
11g · Fees: other
total $17,074 · program services $12,492 · management and general $4,582
-
12 · Advertising and promotion
total $0
-
13 · Office expenses
total $63,518 · program services $45,098 · management and general $18,420
-
14 · Information technology
total $0
-
15 · Royalties
total $0
-
16 · Occupancy
total $366,266 · program services $260,049 · management and general $106,217
-
17 · Travel
total $43,557 · program services $43,557
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $0
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $31,051 · program services $22,046 · management and general $9,005
-
23 · Insurance
total $236,401 · program services $206,607 · management and general $29,794
-
24a · Other expenses: Medical research supplies
total $1,592,737 · program services $1,592,737
-
24b · Other expenses: Charge for research lab use
total $821,677 · program services $821,677
-
24c · Other expenses: Research equipment
total $381,687 · program services $381,687
-
24d · Other expenses: Tuition for researchers
total $66,120 · program services $66,120
-
24e · All other expenses
total $133,719 · program services $90,266 · management and general $43,453
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $572,693 · end of year $1,750,906
-
2 · Savings and temporary cash investments
end of year $0
-
3 · Pledges and grants receivable
end of year $0
-
4 · Accounts receivable
beginning of year $284,990 · end of year $245,846
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $154,984 · end of year $200,426
-
10a · Land, buildings and equipment: cost or other basis
$4,434,562
-
10b · Land, buildings and equipment: accumulated depreciation
$1,890,306
-
10c · Land, buildings and equipment, net
beginning of year $2,941,572 · end of year $2,544,256
-
11 · Investments: publicly traded securities
beginning of year $82,679,826 · end of year $101,051,932
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
beginning of year $26,051,698 · end of year $24,779,102
-
17 · Accounts payable and accrued expenses
beginning of year $7,117,332 · end of year $7,121,038
-
27 · Net assets without donor restrictions
beginning of year $65,038,437 · end of year $82,886,840
-
28 · Net assets with donor restrictions
beginning of year $40,529,994 · end of year $40,564,590
Mission and programs · 2023
Mission
The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.
Activities or mission (Part I)
The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind.
-
A research project at Baylor College of Medicine in gene and protein therapy focuses on inappropriate cell division and cell death within the human body. Much of the work is devoted to intraocular angiogenesis, with particular attention to: 1) the signals that control this process, 2) the development of animal models of human ocular disease, and 3) development of potential therapies. New targets have been identified and potential therapeutic agents are being developed and tested for the treatment of wet AMD, Diabetic Retinopathy, and Retinopathy of Prematurity. Patent applications have been filed by RDF, one of the Foundation's supporting entities, on several discoveries arising out of this research. Licensing efforts by RDF resulted in a license to a commercial company that, using project technology, completed a Phase I human clinical trial with gene therapy to treat wet age-related macular degeneration.
Expenses $1,011,043
-
The conduct of a longstanding research program at the University of Texas M. D. Anderson Cancer Center, the purpose of which is to design and develop novel targeted therapeutic agents that target a powerful human toxin to specifically destroy cancer cells for the treatment of numerous cancer targets and other disease indications. A number of collaborations have been undertaken with researchers at various institutions (e.g., University of California San Diego). Patent applications have been filed by Research Development Foundation (RDF), a tax exempt supporting organization of the Foundation (see schedule R, Part III), on more than twenty discoveries, and a number of patents have been issued. Licensing efforts have been ongoing and have resulted in several licenses.
Expenses $967,238
-
A research program at Baylor College of Medicine in Houston is directed toward glaucoma, the second leading cause of permanent blindness in the world. More than 3 million Americans live with glaucoma, and it is estimated that perhaps millions more remain undiagnosed. The research includes opportunities to treat intraocular pressure (IOP) in a more targeted way that is independent of current medical therapies. State of the art technologies have been developed and are being used to analyze and characterize the molecular changes associated with the early stages of the diseases. The researchers objective is the identification of new potential therapies for glaucoma.
Expenses $823,853
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Jarred W Sloan
Trustee, President, Treasurer
- Total calculated
- $761,256
- From this org
- $274,083
- From related orgs
- $389,373
- Other
- $97,800
- Hours/week
- 20 + 20 related
Schedule J breakdown matched by us
- Base
- $274,083 + $389,373 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $76,593 + $21,207 related
- Filer's total
- $350,676 + $410,580 related
-
Robert M Wallace
Trustee, Vice President
- Total calculated
- $761,256
- From this org
- $203,370
- From related orgs
- $460,086
- Other
- $97,800
- Hours/week
- 20 + 20 related
Schedule J breakdown matched by us
- Base
- $203,370 + $460,086 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $65,986 + $31,814 related
- Filer's total
- $269,356 + $491,900 related
-
Lynn P Carter
Trustee
- Total calculated
- $761,256
- From this org
- $97,315
- From related orgs
- $566,141
- Other
- $97,800
- Hours/week
- 8 + 32 related
Schedule J breakdown matched by us
- Base
- $97,315 + $566,141 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- not reported + $97,800 related
- Filer's total
- $97,315 + $663,941 related
-
Joan S Dunlap
Trustee, VP, Secretary
- Total calculated
- $588,105
- From this org
- $126,473
- From related orgs
- $373,613
- Other
- $88,019
- Hours/week
- 4 + 36 related
Schedule J breakdown matched by us
- Base
- $126,473 + $373,613 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $58,689 + $29,330 related
- Filer's total
- $185,162 + $402,943 related
-
Brian W Crozier
Trustee, Chairman
- Total calculated
- $395,392
- From this org
- $97,315
- From related orgs
- $247,991
- Other
- $50,086
- Hours/week
- 5 + 10 related
Schedule J breakdown matched by us
- Base
- $97,315 + $247,991 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $50,086
- Filer's total
- $147,401 + $247,991 related
-
Thomas J Brorby
Trustee, Deceased
- Total calculated
- $303,562
- From this org
- $80,872
- From related orgs
- $206,090
- Other
- $16,600
- Hours/week
- 5 + 10 related
Schedule J breakdown matched by us
- Base
- $80,872 + $206,090 related
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $16,600
- Filer's total
- $97,472 + $206,090 related
-
Robert L Evans
VP, Assistant Treasurer
- Total calculated
- $291,846
- From this org
- $210,000
- From related orgs
- $0
- Other
- $81,846
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $210,000
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $81,846
- Filer's total
- $291,846
-
Kimberly A Shipley
Assistant Secretary
- Total calculated
- $249,603
- From this org
- $173,267
- From related orgs
- $0
- Other
- $76,336
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $173,267
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $76,336
- Filer's total
- $249,603
-
Lawrence H Cheung
Project Researcher
- Total calculated
- $154,441
- From this org
- $114,406
- From related orgs
- $0
- Other
- $40,035
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $114,406
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $40,035
- Filer's total
- $154,441
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · First-class or charter travel
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Part I, Line 1a: Relevant information in regards to selections on 1a.
- Part II, Compensation from Unrelated Organizations
- Part I Line 1a: Foundation representatives on Foundation business may travel first class under the travel policy approved by the Board, but such persons sometimes fly economy, depending upon routes and convenience of flight schedules. The travel policy does not permit charter travel, and no charter travel was provided to any of such persons.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
The University of Texas MD Anderson Cancer Center
$100,000
Gen Purpose
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(c)(2) · Title Holding Corporation · TX · controlled entity
Directly controlled by Clayton Foundation for Research
-
501(c)(3) · Medical research · NV
Directly controlled by NA
-
Clayton Medical Research Foundation Inc
501(c)(3) · Medical Research · DE
Directly controlled by NA
-
Research Development Foundation
501(c)(3) · Technology Transfer · NV
Directly controlled by NA
-
Institut Clayton de la Recherche
Exempt Swiss Charity · Medical research · SZ
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
Foundation Services Inc
C · Holding Company · NV
Directly controlled by NA
-
Clayton Biotechnologies Inc
C · Technology Transfer · NV · controlled entity
Directly controlled by Found Services Inc
-
Julie Davis Clayton Trust
T · Charitable Remainder Trust · TX
Directly controlled by Clayton Foundation
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 14 November 2024
- IRS schema version
- 2023v5.1
- Source object
- 202443199349310679
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.